Literature DB >> 26935422

Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses.

Chandrika J Piyathilake1, Nicholas J Ollberding2, Ranjit Kumar3, Maurizio Macaluso2, Ronald D Alvarez4, Casey D Morrow5.   

Abstract

It is increasingly recognized that microbes that reside in and on human body sites play major roles in modifying the pathogenesis of several diseases, including cancer. However, specific microbes or microbial communities that can be mechanistically linked to cervical carcinogenesis remain largely unexplored. The purpose of the study was to examine the association between cervical microbiota and high-grade cervical intraepithelial neoplasia (CIN 2+) in women infected with high-risk (HR) human papillomaviruses (HPV) and to assess whether the cervical microbiota are associated with oxidative DNA damage as indicated by the presence of cervical cells positive for 8-hydroxy-2'-deoxyguanosine. The study included 340 women diagnosed with CIN 2+ (cases) and 90 diagnosed with CIN 1 (non-cases). Microbiota composition was determined by Illumina sequencing of the 16S rRNA gene amplified from DNA extracted from cervical mucus samples. Measures of alpha/beta-diversity were not associated with either CIN severity or oxidative DNA damage. However, a cervical mucosal community type (CT) dominated by L. iners and unclassified Lactobacillus spp was associated with CIN 2+ (OR = 3.48; 95% CI, 1.27-9.55). Sequence reads mapping to Lactobacillaceae, Lactobacillus, L. reuteri, and several sub-genus level Lactobacillus operational taxonomic units were also associated with CIN 2+ when examined independently (effect size >2.0; P < 0.05). Our 16S rRNA sequencing results need confirmation in independent studies using whole-genome shotgun sequencing and that would allow sharpening the suggested associations at finer taxonomic levels. Our results provide little evidence that DNA oxidative damage mediates the effect of the microbiome on the natural history of HPV infection and CIN severity. Cancer Prev Res; 9(5); 357-66. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26935422      PMCID: PMC4869983          DOI: 10.1158/1940-6207.CAPR-15-0350

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  78 in total

Review 1.  Redox signaling mediated by the gut microbiota.

Authors:  Andrew S Neish
Journal:  Free Radic Res       Date:  2013-10-04

2.  Higher levels of oxidative DNA damage in cervical cells are correlated with the grade of dysplasia and HPV infection.

Authors:  Giuseppa Visalli; Romana Riso; Alessio Facciolà; Placido Mondello; Carmela Caruso; Isa Picerno; Angela Di Pietro; Pasquale Spataro; Maria Paola Bertuccio
Journal:  J Med Virol       Date:  2015-07-21       Impact factor: 2.327

Review 3.  The gut microbiota, bacterial metabolites and colorectal cancer.

Authors:  Petra Louis; Georgina L Hold; Harry J Flint
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

4.  Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community.

Authors:  M R Oliva; F Ripoll; P Muñiz; A Iradi; R Trullenque; V Valls; E Drehmer; G T Sáez
Journal:  Mol Carcinog       Date:  1997-04       Impact factor: 4.784

5.  Towards the human intestinal microbiota phylogenetic core.

Authors:  Julien Tap; Stanislas Mondot; Florence Levenez; Eric Pelletier; Christophe Caron; Jean-Pierre Furet; Edgardo Ugarte; Rafael Muñoz-Tamayo; Denis L E Paslier; Renaud Nalin; Joel Dore; Marion Leclerc
Journal:  Environ Microbiol       Date:  2009-07-06       Impact factor: 5.491

6.  Dynamics and associations of microbial community types across the human body.

Authors:  Tao Ding; Patrick D Schloss
Journal:  Nature       Date:  2014-04-16       Impact factor: 49.962

7.  Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group.

Authors:  S L Hillier; R P Nugent; D A Eschenbach; M A Krohn; R S Gibbs; D H Martin; M F Cotch; R Edelman; J G Pastorek; A V Rao
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

8.  Bacterial vaginosis and the natural history of human papillomavirus.

Authors:  Caroline C King; Denise J Jamieson; Jeffrey Wiener; Susan Cu-Uvin; Robert S Klein; Anne M Rompalo; Keerti V Shah; Jack D Sobel
Journal:  Infect Dis Obstet Gynecol       Date:  2011-08-16

9.  Identification and genotyping of bacteria from paired vaginal and rectal samples from pregnant women indicates similarity between vaginal and rectal microflora.

Authors:  Nabil Abdullah El Aila; Inge Tency; Geert Claeys; Hans Verstraelen; Bart Saerens; Guido Lopes Dos Santos Santiago; Ellen De Backer; Piet Cools; Marleen Temmerman; Rita Verhelst; Mario Vaneechoutte
Journal:  BMC Infect Dis       Date:  2009-10-14       Impact factor: 3.090

10.  Advancing our understanding of the human microbiome using QIIME.

Authors:  José A Navas-Molina; Juan M Peralta-Sánchez; Antonio González; Paul J McMurdie; Yoshiki Vázquez-Baeza; Zhenjiang Xu; Luke K Ursell; Christian Lauber; Hongwei Zhou; Se Jin Song; James Huntley; Gail L Ackermann; Donna Berg-Lyons; Susan Holmes; J Gregory Caporaso; Rob Knight
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

View more
  43 in total

Review 1.  When human cells meet bacteria: precision medicine for cancers using the microbiota.

Authors:  Han Zhang; Litao Sun
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

Review 2.  Does the vaginal microbiota play a role in the development of cervical cancer?

Authors:  Maria Kyrgiou; Anita Mitra; Anna-Barbara Moscicki
Journal:  Transl Res       Date:  2016-07-15       Impact factor: 7.012

3.  Expression of p16INK4A in cervical precancerous lesions that is unlikely to be preventable by human papillomavirus vaccines.

Authors:  Suguna Badiga; Michelle M Chambers; Warner Huh; Isam-Eldin A Eltoum; Chandrika J Piyathilake
Journal:  Cancer       Date:  2016-08-01       Impact factor: 6.860

Review 4.  Anticancer effects of the microbiome and its products.

Authors:  Laurence Zitvogel; Romain Daillère; María Paula Roberti; Bertrand Routy; Guido Kroemer
Journal:  Nat Rev Microbiol       Date:  2017-05-22       Impact factor: 60.633

5.  Moving forward with human papillomavirus immunotherapies.

Authors:  Nicolas Çuburu; John T Schiller
Journal:  Hum Vaccin Immunother       Date:  2016-07-07       Impact factor: 3.452

Review 6.  The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.

Authors:  Travis T Sims; Lauren E Colbert; Ann H Klopp
Journal:  J Immunother Precis Oncol       Date:  2020-09-14

Review 7.  Vaginal microbiomes and ovarian cancer: a review.

Authors:  Jinyun Xu; Jing-Jie Peng; Wenqing Yang; Kun Fu; Yu Zhang
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

Review 8.  Systematic Review: The Impact of Cancer Treatment on the Gut and Vaginal Microbiome in Women With a Gynecological Malignancy.

Authors:  Ann Muls; Jervoise Andreyev; Susan Lalondrelle; Alexandra Taylor; Christine Norton; Ailsa Hart
Journal:  Int J Gynecol Cancer       Date:  2017-09       Impact factor: 3.437

Review 9.  Role of Vaginal Microbiota Dysbiosis in Gynecological Diseases and the Potential Interventions.

Authors:  Yiwen Han; Zhaoxia Liu; Tingtao Chen
Journal:  Front Microbiol       Date:  2021-06-18       Impact factor: 5.640

Review 10.  The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.

Authors:  Erik Kudela; Alena Liskova; Marek Samec; Lenka Koklesova; Veronika Holubekova; Tomas Rokos; Erik Kozubik; Terezia Pribulova; Kevin Zhai; Dietrich Busselberg; Peter Kubatka; Kamil Biringer
Journal:  EPMA J       Date:  2021-05-18       Impact factor: 8.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.